Determinants of high sessile serrated lesion detection: Role of faecal occult blood test and colonoscopy quality indicators

Table 6 Polypectomy and detection rates by indication

Comparisons	Statistics
	OR	95%CI	P value
Indication
FOBT (+)/clinical symptoms	2.299	1.203-4.396	0.004a
Surveillance (previous patient)/clinical symptoms	1.229	0.829-1.824	0.610
FOBT (+)/surveillance (previous patient)	1.870	1.02-3.43	0.039a
Surveillance (new patient)/clinical symptoms	1.898	0.912-3.953	0.120
FOBT (+)/surveillance (new patient)	1.211	0.508-2.888	0.975
Surveillance (new patient)/surveillance (previous patient)	1.544	0.767-3.108	0.437
Screening/clinical symptoms	1.386	0.625-3.073	0.797
FOBT (+)/screening	1.659	0.656-4.194	0.570
Screening/surveillance (previous patient)	1.128	0.52-2.444	0.993
Surveillance (new patient)/screening	1.370	0.51-3.679	0.909
Bowel preparation status
Adequate/inadequate	2.578	1.119-5.939	0.021a
Good/inadequate	2.430	1.082-5.458	0.027a
Adequate /good	1.061	0.748-1.504	0.917
Serrated polyposis syndrome status (grouped diagnoses)
SPS diagnosis (new or prior)/SPS absent	3.723	2.473-5.606	< 0.001a
Inflammatory bowel disease status
IBD absent/IBD present	2.332	1.073-5.065	0.032a
Endoscopist
Endoscopist 1/endoscopist 2	1.43	1.01-2.02	0.043a
Patient sex
Male/female	1.021	0.805-1.296	0.861

^aP values < 0.05.

Comparisons are made such that all odds ratios are greater than 1 for ease of interpretation odds ratios > 1 for ease of interpretation. OR: Odds ratio; CI: Confidence interval; FOBT (+): Faecal occult blood test positive; IBD: Inflammatory bowel disease.